Hanlon Investment Management »

Arrowhead Pharmaceuticals shares owned by Hanlon Investment Management

Quarter-by-quarter ownership of Arrowhead Pharmaceuticals (ARWR) shares owned by Hanlon Investment Management from 13F filings

Historical chart of Hanlon Investment Management investment in Arrowhead Pharmaceuticals

Tip: Access up to 7 years of quarterly data

All positions including Arrowhead Pharmaceuticals held by Hanlon Investment Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Arrowhead Pharmaceuticals by Hanlon Investment Management

Quarter filed Position value Share count Share price at filing
2026-06-30 $777k 9.5k 81.51

More positions owned by Hanlon Investment Management

Ishares Tr 0-3 Mth Treasury (SGOV)
NVIDIA Corporation (NVDA)
Ishares Tr Iboxx Hi Yd Etf (HYG)
Flexshares Tr Qualt Divd Idx (QDF)
Flexshares Tr Intl Qltdv Idx (IQDF)
Ishares Tr Core S&p500 Etf (IVV)
Ishares Tr 7-10 Yr Trsy Bd (IEF)
Carpenter Technology Corporation (CRS)
Broadcom (AVGO)
Amphenol Corp Cl A (APH)
Vanguard Index Fds Small Cp Etf (VB)
Vanguard Index Fds Growth Etf (VUG)
Ge Vernova (GEV)
Vanguard Tax-managed Fds Van Ftse Dev Mkt (VEA)
Apple (AAPL)

View all positions for Hanlon Investment Management

Top funds holding Arrowhead Pharmaceuticals

BlackRock
venBio Select Advisor
FMR
Vanguard Portfolio Management
State Street Corporation
Vanguard Capital Management
Geode Capital Management
Fred Alger Management
Invesco
Vestal Point Capital
Baker Bros. Advisors
Susquehanna International
Goldman Sachs Group
Northern Trust
Siren

View all funds holding Arrowhead Pharmaceuticals